CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation

J Wang - Expert review of molecular diagnostics, 2009 - Taylor & Francis
Most immunosuppressive drugs have a narrow therapeutic index and large interpatient
variabilities in their pharmacokinetic and pharmacodynamic profiles. Identification of …
被引用次数：34 相关文章

CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation

J Wang - Expert Review of Molecular Diagnostics, 2009 - go.gale.com
Transplant patients continually suffer the risk of underimmunosuppression, with loss of the
graft, or overimmunosuppression with infection and lymphoproliferative disease. Most of the …

CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation

J Wang - Expert Review of Molecular Diagnostics, 2009 - search.proquest.com
Most immunosuppressive drugs have a narrow therapeutic index and large interpatient
variabilities in their pharmacokinetic and pharmacodynamic profiles. Identification of …

CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation

J Wang - Expert review of molecular diagnostics, 2009 - pubmed.ncbi.nlm.nih.gov
Most immunosuppressive drugs have a narrow therapeutic index and large interpatient
variabilities in their pharmacokinetic and pharmacodynamic profiles. Identification of …

CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.

J Wang - Expert Review of Molecular Diagnostics, 2009 - europepmc.org
Most immunosuppressive drugs have a narrow therapeutic index and large interpatient
variabilities in their pharmacokinetic and pharmacodynamic profiles. Identification of …